Le Lézard
Classified in: Health
Subject: SVY

Negative-pressure Wound Therapy Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2026


NEW YORK, May 20, 2019 /PRNewswire/ --  

Global Negative-pressure Wound Therapy Devices Market: Overview
The global negative-pressure wound therapy devices market report comprises an elaborate executive summary, which includes a snapshot that provides information about various segments of the market.It also provides information and data analysis of the global market with respect to the segments based on product, application, end-user, and region.



Read the full report: https://www.reportlinker.com/p05775479/?utm_source=PRN



A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the overview section.Additionally, the section comprises competitive matrix and company profiles along with business overview to understand the competitive landscape in the market.

This section of the report also provides market attractiveness analysis by region, thereby presenting a thorough analysis of the overall competitive scenario in the global negative-pressure wound therapy devices market.

Global Negative-pressure Wound Therapy Devices Market: Key Segments
In terms of product, the global negative-pressure wound therapy devices market has been segmented into single-use NPWT devices and conventional NPWT devices.Based on application, the market has been divided into diabetic foot ulcers, pressure ulcers, venous leg ulcers, burn wounds, surgical wounds, and others.

Based on end-user, the global market has been classified into hospital & clinics, ambulatory surgical centers, and homecare settings.The hospital & clinics segment is anticipated to expand at a high CAGR during the forecast period.

The market has been analyzed based on price variations, technology trend, and presence of key players. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.

Global Negative-pressure Wound Therapy Devices Market: Regional Outlook
In terms of region, the global negative-pressure wound therapy devices market has been segmented into five major regions: North America (the U.S. and Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East (South Africa, GCC Countries, Israel, and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries/sub-regions have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions.

Companies Mentioned in Report
The report also profiles the major players in the market in terms of attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Key companies profiled in the global negative-pressure wound therapy devices market include SMITH AND NEPHEW, KCI (ACELITY), Cardinal Health, PAUL HARTMANN, ConvaTec Inc., DeRoyal, Genadyne Biotechnologies, Inc., Medela, Inc. ATMOS MedizinTechnik GmbH & Co. KG, Talley Group Ltd, and Lohmann & Rauscher.

The global Negative-Pressure wound therapy devices market has been segmented as follows:

Global Negative-pressure Wound Therapy Devices Market, by Product
Single-use NPWT Devices
Conventional NPWT Devices

Global Negative-pressure Wound Therapy Devices Market, by Application
Diabetic foot ulcers
Pressure ulcers
Venous leg ulcers
Burn wounds
Surgical wounds
Others

Global Negative-pressure Wound Therapy Devices Market, by End-user
Hospital & Clinics
Ambulatory surgical centers (ASCs)
Homecare settings

Global Negative-pressure Wound Therapy Devices Market, by Region
North America
US.
Canada
Europe
Germany
U.K.
France
Spain
Italy
Rest of Europe
Asia Pacific
China
Japan
Australia
India
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
South Africa
GCC Countries
Israel
Rest of Middle East & Africa

Read the full report: https://www.reportlinker.com/p05775479/?utm_source=PRN

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001 

SOURCE Reportlinker


These press releases may also interest you

at 00:05
ImmunityBio, Inc. , an immunotherapy company, today announced positive overall survival results in the QUILT 3.055 study of 2nd- and 3rd-line NSCLC patients who progressed after checkpoint inhibitor therapy (pembrolizumab, nivolumab, or atezolizumab)...

at 00:05
The Insurance Institute for Highway Safety is updating its vehicle-to-vehicle front crash prevention test to address crashes that occur at higher speeds and those in which the struck vehicle is a motorcycle or large truck. Only one of the first 10...

at 00:00
Nutriessential.com recently announced its expansion into Oceania, Asia, and the Gulf. The company has been providing science-backed GMP-certified supplements in the US, Europe and Canada since 2005 and decided to expand owing to rising global demands...

24 avr 2024
Summit Clinical Research LLC ("Summit") is deeply saddened by the death of Co-Founder and Chairman Dr. Stephen Harrison. Summit mourns Dr. Harrison and extends its heartfelt condolences to his family and loved ones.   During an illustrious 30-year...

24 avr 2024
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Drug...

24 avr 2024
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...



News published on and distributed by: